FDA Inspection 1080159 — Janssen Research & Development, LLC

Janssen Research & Development, LLC — FEI 3009708653

The FDA completed an inspection of Janssen Research & Development, LLC on Feb 4, 2019 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 4, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.